News | 17 August 2012
LONDON (Reuters) - Investor HgCapital has sold British pharmaceutical company Mercury Pharma to private equity firm Cinven for 465 $732 million. "The realization of Mercury Pharma marks the continued development of HgCapital's investment focus in the ...
Click on the link to read the full article at Reuters UK
(This link will open in a new window)